Concepedia

Louis Fries

LF

Statistics

Publications

74

Citations

7.3K

H-Index

45

Active since

1985

Affiliations

Novavax (United States)(Current)

Johns Hopkins University

GlaxoSmithKline (United States)

Baylor College of Medicine

Novavax (Sweden)

Louis Fries is an author at Novavax (United States) specializing in vaccinology, immunology, and vaccination.

ORCID

Publications per year

1985–2025

74

Publications

74

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gary Albert, Iksung Cho et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

, , +17

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Jing-Hui Tian, Nita Patel, Robert Haupt et al. · Nature Communications · 2021 · 526 citations · Full text

, , +16

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · The Lancet · 2021 · 458 citations · Full text

, , +16

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

Shabir A. Madhi, Fernando P. Polack, Pedro A. Piedra et al. · New England Journal of Medicine · 2020 · 424 citations · Full text

, , +17

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Shelly McNeil, Scott A. Halperin, Joanne M. Langley et al. · Clinical Infectious Diseases · 2005 · 305 citations · Full text

, , +17

1–5 of 74